"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effect of pentoxifylline 400 mg twice daily
administration on the prevention of paclitaxel-Induced peripheral neuropathy in breast cancer
patients.